FDA Changes to CBD Market Bullish for MetWood (MTWD)

Cannabis

(NEW YORK)–Metwood, Inc. (OTC:MTWD) recently acquired a health supplement manufacturer, which could position the company as potential play with upcoming FDA regulatory changes to the CBD market.

On June 29, 2019 MTWD entered into a merger agreement with Emerge Nutraceuticals, Inc., and appointed Keith M. Thomas CEO, and Shawn Phillips President.

What Do They Do?

EMERGE offers Full Service Supplement Manufacturing with state-of-the-art FDA registered facilities, ensuring the highest quality and highest potency products. In short EMERGE offers manufacturing, packaging, and labeling solutions for health supplement companies looking to produce their products for commercial markets.

About New President

Shawn Phillips is the author of the best-selling books, ABSolution and Strength for Life, as well as thousands of articles on health, fitness, nutrition, mindset, motivation, and more. In these publications, Shawn brings perspective and depth to the questions most fear to ask.

Alongside his brother, Bill, Shawn was instrumental in the explosive success of EAS and the Body For Life movement. He pioneered the computerized strength system, Powerbuilding, launched an online supplement knowledge base (Nutros.com) and is the founder of the “lifestyle nutrition” company, Full Strength Nutrition-which helps men live freer, clearer and stronger in the prime of life.

Bullish Play on FDA Regulation of CBD

MTWD having FDA registered facilities right away makes this stock one of the more attractive plays within the CBD sector.

How so? Well, as the FDA imposes new rules regulating CBD infused products one of the requirements may be that CBD companies produce their products in GMP and FDA registered facilities, and re-word their labels to comply with proper disclosures. These are all things MTWD offers right now, and could position them to be a big winner in upcoming changes in FDA rules regarding CBD production.

If you are looking for a way to play the upcoming regulatory change in CBD market then MTWD, and their new merger, may be one to add to your watch list.

MetWood, Inc. is publicly traded under the ticker symbol “MTWD”, and currently has a public float of just under 4 million shares https://www.otcmarkets.com/stock/MTWD/quote

About Metwood

MetWood, Inc. (OTC:MTWD) is a health supplement manufacturer that provides packaging and labeling solution through their state-of-the-art FDA registered facilities. The management team holds years of experience within the health and supplement industry through ist leadership of Shawn Phillps as President. For more information visit www.emergenutraceuticals.com

Disclaimer:
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. In Compliance with SEC Rule 17B WSNC was compensated two thousand three hundred dollars for on going media services. WSNC, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. As of date of this alert, WSNC, or any of its affiliates, held no positions in securities mentioned above. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial adviser before any and all investments.
Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
High Risk
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial adviser before making any and all investment decisions when investing in these type of securities

Share